Colgate-Palmolive (CL) Financials

Colgate-Palmolive’s recent results show improving sales momentum and strong cash generation, although earnings have softened from the unusually strong levels reported in 2025. The company’s balance sheet has also improved in some areas, but its very low equity base and substantial long-term debt remain important risks for investors.

• Revenue growth has accelerated. Q2 2026 revenue increased to $5.36 billion from $5.11 billion in Q2 2025, a gain of approximately 5%. Q1 2026 revenue rose approximately 8% year over year, while Q4 2025 revenue increased nearly 6% from the prior-year quarter.
• Gross margin has generally improved. Q2 2026 gross profit was $3.30 billion, producing a gross margin of approximately 61.5%, compared with 60.1% in Q2 2025. This suggests pricing, mix or cost management has helped offset higher operating expenses.
• Operating cash flow remains strong and is improving year over year. Cash flow from operations reached $995 million in Q2 2026, up from $884 million in Q2 2025. Q1 2026 operating cash flow of $747 million was also well above the $600 million recorded in Q1 2025.
• Free cash flow supports shareholder returns. After capital expenditures of $128 million, Q2 2026 operating cash flow implied approximately $867 million of free cash flow. That was more than enough to fund $462 million of dividends and $291 million of share repurchases during the quarter.
• Share count continues to decline. Diluted weighted-average shares fell to approximately 797 million in Q2 2026 from 808 million in Q2 2025 and 817 million in Q2 2024. Continued repurchases have helped support per-share results, even as total net income has weakened.
• Liquidity has improved from the prior year. Cash and equivalents rose to $1.37 billion at June 30, 2026, from $1.22 billion a year earlier. The company also moved from negative working capital in Q2 2025 to modest positive working capital in Q2 2026, with current assets of $6.31 billion versus current liabilities of $6.15 billion.
• Debt has declined recently but remains significant. Total debt was approximately $7.86 billion at the end of Q2 2026, down from about $8.76 billion in Q2 2025 and $8.77 billion at year-end 2022. However, long-term debt still represented $7.82 billion, making interest rates and refinancing conditions important factors.
• Capital spending remains relatively controlled. Quarterly purchases of property, plant and equipment have generally ranged from roughly $108 million to $197 million across the provided periods. This keeps capital intensity manageable, although the company must continue investing in manufacturing capacity and brand support.
• Net income and operating income are below comparable 2025 levels. Q2 2026 net income attributable to common shareholders declined to $693 million from $743 million in Q2 2025, while diluted EPS fell to $0.86 from $0.91. Q1 2026 diluted EPS of $0.80 was also below $0.85 a year earlier.
• The balance sheet has a very thin equity cushion. Total equity and noncontrolling interests were only $566 million against $16.22 billion of liabilities at June 30, 2026. Goodwill and intangible assets totaled approximately $4.60 billion, so investors should monitor leverage, asset valuations and the company’s ability to maintain cash generation.

Overall, Colgate-Palmolive is producing growing revenue and increasingly reliable operating cash flow, while share repurchases continue to reduce the share count. The main concern is that profit growth has not kept pace with sales growth in 2026, and the company continues to operate with substantial leverage relative to its reported equity base. Investors should also use caution when comparing periods because several historical figures in the data set were restated or calculated, and the Q4 2025 income statement contains an apparent inconsistency between reported operating expenses and operating income.